Gambia vs Uganda: Cause of death, by non-communicable diseases, ages 15-59, male
Gambia
34.6%
in 2021
Uganda
35.6%
in 2021
Gambia rank
157th
Uganda rank
156th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Gambia
- Uganda
How they compare
Uganda currently reports 35.6% against 34.6% in Gambia, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Gambia ahead.
Gambia ranks 157th and Uganda ranks 156th of 185 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.0% | 19.1% | 21.0% | Gambia |
| 2010s | 38.9% | 31.2% | 7.7% | Gambia |
| 2020s | 36.7% | 35.1% | 1.6% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Gambia or Uganda?
- Uganda, at 35.6% against 34.6% in Gambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Gambia and Uganda?
- 1.0%, with Uganda ahead.
- How many years of comparable data are there for Gambia and Uganda?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Uganda rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Gambia ranks 157th and Uganda ranks 156th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.